The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)

被引：0
|
作者：
Ko, Jenny J.
Xie, Wanling
Heng, Daniel Yick Chin
Kroeger, Nils
Lee, Jae-Lyun
Rini, Brian I.
Knox, Jennifer J.
Bjarnason, Georg A.
Harshman, Lauren Christine
Pal, Sumanta Kumar
Yuasa, Takeshi
Smoragiewicz, Martin
Donskov, Frede
Bamias, Aristotelis
Wood, Lori
Ernst, D. Scott
Agarwal, Neeraj
Vaishampayan, Ulka N.
Rha, Sun Young
Choueiri, Toni K.
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Med Greifswald, Dept Urol, Greifswald, Germany
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[10] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[11] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[13] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[14] Alexandra Peripheral Gen Hosp, Athens, Greece
[15] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[16] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[17] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[18] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[19] Yonsei Univ, Coll Med, Seoul, South Korea
[20] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页数：1
相关论文
共 50 条
  • [1] International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
    Ko, Jenny J.
    Xie, Wanling
    Kroeger, Nils
    Lee, Jae-Lyun
    Rini, Brian I.
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Srinivas, Sandy
    Pal, Sumanta K.
    Yuasa, Takeshi
    Smoragiewicz, Martin
    Donskov, Frede
    Kanesvaran, Ravindran
    Wood, Lori
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun-young
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    LANCET ONCOLOGY, 2015, 16 (03): : 293 - 300
  • [2] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Brugarolas, James
    Broom, Reuben James
    Bamias, Aristotelis
    Yuasa, Takeshi
    Srinivas, Sandhya
    Ernst, D. Scott
    Pezaro, Carmel Jo
    Wood, Lori
    Kollmannsberger, Christian K.
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Swierkowski, Marcin
    Wells, Connor
    Fraccon, Anna Paola
    La Russa, Francesca
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Beuselinck, Benoit
    Wood, Lori
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Roussel, Eduard
    Kinget, Lisa
    Beuselinck, Benoit
    Albersen, Maarten
    Wells, Connor
    Ernst, Matthew Scott
    Donskov, Frede
    Schmidt, Andrew Lachlan
    Szabados, Bernadett
    Pal, Sumanta K.
    Meza, Luis A.
    Agarwal, Neeraj
    Weickhardt, Andrew James
    Davis, Ian D.
    Alva, Ajjai Shivaram
    Wood, Lori
    Porta, Camillo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Navani, Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [5] Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Stukalin, Igor
    Wells, Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Porta, Camillo
    Moreira, Raphael Brandao
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
    Stukalina, Igor
    Wellsa, J. Connor
    Donskovb, Frede
    Rinic, Brian I.
    Leed, Jae-Lyun
    Bjarnasone, Georg A.
    Beuselinckf, Benoit
    Smoragiewicz, Martin
    Alvah, Ajjai Shivaram
    Srinivasi, Sandy
    Woodi, Lori
    Saleemk, Sadia
    Pal, Sumanta Kumar
    Yuasam, Takeshi
    Broomn, Reuben James
    Kanesvaran, Ravindran
    Bamiasp, Aristotelis
    Knoxq, Jennifer J.
    Henga, Daniel Y. C.
    Choueirir, Toni K.
    BJU INTERNATIONAL, 2015, 116 : 21 - 21
  • [7] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma treated with first-line combination immunotherapies: Results from the International metastatic renal cell carcinoma database consortium (IMDC)
    Takemura, K.
    Yuasa, T.
    Lemelin, A.
    Ferrier, E.
    Wells, J. C.
    Saad, E.
    Saliby, R. M.
    Basappa, N. S.
    Wood, L. A.
    Jude, E.
    Pal, S. K.
    Donskov, F.
    Beuselinck, B.
    Szabados, B. E.
    Powles, T. B.
    Mckay, R. R.
    Gebrael, G.
    Agarwal, N.
    Choueiri, T. K.
    Heng, D. Y. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1558 - S1559
  • [10] Characteristics of metastatic renal cell carcinoma (mRCC) patients treated with delayed targeted therapy: Results from the International mRCC Consortium (IMDC).
    Li, Haoran
    Choueiri, Toni K.
    Wells, Connor
    Agarwal, Neeraj
    Donskov, Frede
    Lee, Jae-Lyun
    Broom, Reuben James
    Yuasa, Takeshi
    Rini, Brian I.
    Pal, Sumanta Kumar
    Wood, Lori
    Ernst, D. Scott
    Kollmannsberger, Christian K.
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Bjarnason, Georg A.
    Knox, Jennifer J.
    Saleem, Sadia
    Beuselinck, Benoit
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345